120 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
4 Jan 24
Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates
4:01pm
norovirus proteases, which have caused the majority of norovirus outbreaks worldwide since 2002, and a favorable pharmacokinetic property targeting
424B5
ujqu k985pjz
15 Jun 23
Prospectus supplement for primary offering
4:54pm
8-K
dvv9lj7thzbu idglxi9
3 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:30pm
DEFA14A
yhrl3myybd7o74yq
7 Jun 21
Additional proxy soliciting materials
8:30am
8-K
EX-1.1
5uq q9b9vei2jngki
5 May 21
Entry into a Material Definitive Agreement
5:02pm
424B5
8fewac nn
5 May 21
Prospectus supplement for primary offering
4:01pm